Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A dose homogeneity index for evaluating 192Ir interstitial breast implants.

A Wu1, K Ulin, E S Sternick

  • 1Department of Radiation Oncology, Tufts-New England Medical Center, Boston, Massachusetts 02111.

Medical Physics
|January 1, 1988
PubMed
Summary

This study introduces the dose homogeneity index (DHI) to assess 192Ir interstitial breast implant dose uniformity. The DHI helps optimize implant planning for improved treatment efficacy and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing the sociocultural model of eating disorders: A cross-national analysis of income inequality, gender equality, and eating disorder rates.

Social science & medicine (1982)·2026
Same author

Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation.

Clinical and translational radiation oncology·2026
Same author

Numerical study of the effect of the relative mobilities of chemical components on the non-solvent induced phase separation process for membrane elaboration.

The Journal of chemical physics·2025
Same author

From confusion to acceptance: overcoming challenges using a fighting spirit and the power of support - a qualitative study of young adults' experiences in the first year after diagnosis in early onset of chronic inflammatory joint disease.

Scandinavian journal of rheumatology·2025
Same author

Desiccation-induced DNA damage facilitates drug resistance in <i>Mycobacterium tuberculosis</i>.

bioRxiv : the preprint server for biology·2025
Same author

[Evaluation of the performance of the artificial intelligence - enabled snail identification system for recognition of <i>Oncomelania hupensis robertsoni</i> and <i>Tricula</i>].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2025

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Brachytherapy

Background:

  • Ensuring dose homogeneity in interstitial breast implants is crucial for effective radiation therapy.
  • 192Iridium (192Ir) is commonly used for brachytherapy, but optimizing dose distribution remains a challenge.

Purpose of the Study:

  • To define and validate a quantitative metric, the dose homogeneity index (DHI), for evaluating dose homogeneity in 192Ir interstitial breast implants.
  • To compare dose homogeneity between different planning systems (Memorial and Tufts) for 192Ir double-plane implants.

Main Methods:

  • Defined DHI = [V(TDR) - V(HDR)]/V(TDR), where V(TDR) is the total treatment volume and V(HDR) is the volume receiving 1.5x or greater the prescribed dose rate.
  • Applied DHI to analyze 192Ir double-plane implants of varying sizes planned using Memorial and Tufts systems.

Related Experiment Videos

  • Utilized Anderson's volume-dose histogram with inverse square suppression for analysis.
  • Main Results:

    • The DHI provides a quantitative measure to assess and compare dose homogeneity in 192Ir breast implants.
    • The study examined variations in DHI based on implant size and planning system.
    • Suggested criteria for determining the optimal number of planes for implants within specific treatment volumes.

    Conclusions:

    • The developed DHI is a valuable tool for optimizing dose distribution in 192Ir interstitial breast brachytherapy.
    • The findings aid in selecting appropriate implant configurations for improved treatment planning and outcomes.
    • Further research can refine DHI application for personalized breast cancer treatment.